Patent 7449478 was granted and assigned to National Health Research Institutes on November, 2008 by the United States Patent and Trademark Office.
This invention relates to treating peroxisome proliferator-activated receptors related diseases with certain indole compounds. The indole compounds are of formula (I) below. Each variable is defined in the specification.